I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide Intention to pursue a Hong Kong...
Lianlian DigiTech Reports 64.7% Surge in Digital Payment TPV for 2024, with Adjusted Operating Profit Soaring
HANGZHOU, China, March 20, 2025 /PRNewswire/ -- Lianlian DigiTech, a global leader in digital payment and fintech solutions, announced its annual financial results for 2024 on March 18, 2025. As of December 31, 2024, Lianlian DigiTech's total...